JulieVoellerMDFAAP

Pediatric Hematology & Oncology • San Antonio, TX

Assistant Professor

Join to view full profile

Dr. Voeller is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Voeller's full profile

Already have an account?

Office
333 N Santa Rosa
San Antonio, TX 78207
Phone+1 210-704-4275

Education & Training

University of Wisconsin Hospitals and ClinicsFellowship, Pediatric Hematology/Oncology, 2016 - 2019
University of Texas at Austin Dell Medical SchoolResidency, Pediatrics, 2013 - 2016
University of Texas Southwestern Medical SchoolClass of 2013
Stanford UniversityBS, BA, Biological Sciences, International Relations, 2003 - 2007

Certifications & Licensure

TX State Medical License 2019 - 2025
WI State Medical License 2016 - 2019
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

48 citations
Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition.
Julie Voeller, Amy K. Erbe, Jacob Slowinski, Kayla Rasmussen, Peter M. Carlson
Journal for Immunotherapy of Cancer. 2019-12-06
2 citations
Autoimmune Ataxia During Maintenance Therapy for Acute Lymphoblastic Leukemia.
Julie Voeller, Chrysanthy Ikonomidou, Justin Brucker, Carol Diamond, Sharon Frierdich
Child Neurology Open. 2018-12-16
38 citations
Advances in Anti-GD2 Immunotherapy for Treatment of High-risk Neuroblastoma.
Julie Voeller, Paul M. Sondel
Journal of Pediatric Hematology/oncology. 2019-04-01

Journal Articles

Autoimmune Ataxia During Maintenance Therapy for Acute Lymphoblastic Leukemia
Julie Voeller, Child Neurol Open, 12/16/2018
Advances in Anti-GD2 Immunotherapy for Treatment of High-risk Neuroblastoma
Julie Voeller, Paul Sondel, J Pediatr Hematol Oncol, 11/30/2018

Press Mentions

Rapidly Advancing Cancer ImmunotherapyApril 30th, 2019